Compare BELFA & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFA | NEOG |
|---|---|---|
| Founded | 1949 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | BELFA | NEOG |
|---|---|---|
| Price | $182.25 | $9.86 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | 54.9K | ★ 4.1M |
| Earning Date | 02-17-2026 | 01-08-2026 |
| Dividend Yield | ★ 0.13% | N/A |
| EPS Growth | ★ 19.52 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | $649,376,000.00 | ★ $880,319,000.00 |
| Revenue This Year | $28.52 | N/A |
| Revenue Next Year | $6.49 | $2.00 |
| P/E Ratio | $35.93 | ★ N/A |
| Revenue Growth | ★ 23.70 | N/A |
| 52 Week Low | $53.95 | $3.87 |
| 52 Week High | $189.32 | $12.07 |
| Indicator | BELFA | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 76.81 |
| Support Level | $155.74 | $8.93 |
| Resistance Level | $187.73 | $9.78 |
| Average True Range (ATR) | 7.44 | 0.56 |
| MACD | 1.54 | 0.11 |
| Stochastic Oscillator | 85.26 | 89.30 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.